摘要
目的:探讨3种调脂药物对高血脂症所产生的经济效果。方法:160例高血脂症患者分别用3种治疗方案:A组用吉非罗齐,B组用洛伐他汀,C组用多烯康。用成本-效果分析方法比较。结果:A组降低TG、TC、LDL-C分别为43%、9%、10%,适合于Ⅱb、Ⅲ、Ⅳ型高血脂症,效果好,经济合理;B组降低TC、LDL-C分别为21%、25%,适用于Ⅱa、Ⅲb型高血脂症,费用低,效果好;C组降低TC、TG分别为17%、28%,适用于TC、TG高的患者。结论:运用药物经济学理论指导临床合理用药,可使有限资源得到合理配置。
OBJECTIVE: To evaluate the economic effectiveness of three lipid regulation agents in treating patients with hyperlipemia.METHODS: 160 patients with hyperlipemia were divided into three groups: A, B, C.They received different therapeutic shemes: A: gemfibrozil B: lovastatin C: duoxikang.RESULTS: The levels of TG, TC and LDL -C of patients in group A reduced 43% , 9% and 10% respectively, which revealed that gemfibrozil was indicated in Ⅱb, Ⅲ and Ⅳ hyperlipemia with good effect and low cost.The levels of TC and LDL - C decreased 21% and 25% respectively in group B. Lovastatin was used in Ⅱa, Ⅱa hyperlipemia.The levels of TC and TG declined 17% and 28% respectively in group C.Duoxikang was used in patients with high levels of TC and TG.CONCLUSION: It will improve therapeutic effect and decrease cost, if pharmacoeco-nomic cost ?effectiveness analysis is used to guide rational use of lipid regulation agents in clinical practice.
出处
《中国药房》
CAS
CSCD
2001年第4期219-220,共2页
China Pharmacy
关键词
成本-效果分析
调脂药
吉非罗齐
洛伐他汀
多烯康
cost - effect analysis
lipid regulation agent
gemfibrozil
lovastatin
douxikang